LARCHMONT, N.Y.--(BUSINESS WIRE)--LadaTech LLC, which is jointly owned by GlaxoSmithKline (GSK) and IP Finance Holdings, announced today that a jury has found that Illumina Inc. (ILMN) has infringed a patent owned by LadaTech covering essential aspects of the Solexa DNA sequencing technology in a major patent infringement lawsuit in Delaware. (LadaTech, LLC v. Illumina, Inc. and Solexa, Inc., in the United States District Court for the District of Delaware (C. A. No. 09-627-SLR))
